Trial · NCT06292494
Focused Ultrasound for Drug-resistant Epilepsy
NCT06292494, Not applicable, Recruiting, Taipei Veterans General Hospital, Taiwan
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Focused Ultrasound for Drug-resistant Epilepsy. Trials, record NCT06292494. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT06292494
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Focused Ultrasound for Drug-resistant Epilepsy
- NCT number
- NCT06292494
- Status
- Recruiting
- Phases
- Not applicable
- Enrollment
- 10 participants, estimated
- Lead sponsor
- Taipei Veterans General Hospital, Taiwan
- Conditions
- Focused Ultrasound, MR-guided FUS, Drug Refractory Epilepsy, Drug Resistant Epilepsy, Medication Resistant Epilepsy
- Interventions
- Exablate 4000 Transcranial MRgfUS System
- First posted
- 2024-03-05
- Last updated
- 2026-10-16
Source ClinicalTrials.gov
Registered outcomes7
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | pulse rate [Safety] | pre- and post- treatment immediately | vital sign |
| Primary | blood oxygen saturation level [Safety] | pre- and post- treatment immediately | vital sign |
| Primary | MRI [Safety] | pre- and post- treatment immediately | Safety and Tolerability |
| Primary | Incidence of Treatment-Emergent Adverse Events [Tolerability] | during and post- treatment immediately | To record the adverse events |
| Secondary | seizure frequency [efficacy] | pre- and post- treatment immediately and 1,3,6,12 month | The treatment response is assessed based on the overall observation of seizure frequency. |
| Secondary | scalp EEG [efficacy] | pre- and post- treatment immediately and 1,3,6,12 month | The treatment response is assessed based on the scalp EEG (electroencephalogram). |
| Secondary | No. of seizure-free days [efficacy] | pre- and post- treatment immediately and 1,3,6,12 month | The treatment response is assessed based on the number of seizure-free days within the entire monitoring period. |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT06292494
GET https://conductscience.org/api/trials/v1/NCT06292494/registered